IPO Plus

₹0.26

▼ -0.01 -3.70%

11 Sept 2026

BSE Listed

IBC
What does IBC mean?
BSE · Securities under IBCThe company is in the insolvency process. Practical meaning: equity holders often recover little or nothing in resolution, so the exchange restricts price movement to stop speculative churn in a claim that may be extinguished.Criteria: Company admitted to the Corporate Insolvency Resolution Process under the Insolvency & Bankruptcy Code; placed under surveillance with restricted price movement.Exchange notice · 2026-04-24

Supha Pharmachem Limited (539561)

Volume: 11,14,775Avg Vol 1W: 16,27,088Avg Vol 1M: 14,60,73452W Range:₹0.25₹1.8
BSE www.remlife.com AI Report
Key Ratios
Checked just now
Market Cap₹23 Cr
Current Price₹0.26
Previous Close₹0.27
High / Low (52w)₹1.8 / ₹0.25
Volume11,14,775
Avg Vol (1W)16,27,088
Avg Vol (1M)14,60,734
Stock P/E13
Book Value₹1.04
Dividend Yield0%
ROE0%
ROA69.12%
Revenue (TTM)—
Revenue Growth—
Profit Margin229.57%
Total Debt—
Shares Outstanding88 Cr
Face Value—
EPS (TTM)₹0.02
P/B0.25
Debt / Equity26.01
50 DMA₹0.31
200 DMA₹0.64
Day change-3.70%
SurveillanceIBC
Price Chart
₹0.26▼ 82.89% · 1Y
₹3₹09.4Cr
2025-09-11
2026-09-11

20-day avg volume: 14.7L shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 53% YoY.
Quarterly Results
MetricMar 2025Jun 2025Sept 2025
Revenue₹264 Cr₹113 Cr₹111 Cr
EBITDA₹0 Cr₹5 Cr₹11 Cr
Net Profit₹-2 Cr₹5 Cr₹9 Cr
EPS———
Profit & Loss (Annual)
MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025
Revenue₹1,408 Cr₹78 Cr₹25 Cr₹38 Cr₹416 Cr₹82 Cr₹18 Cr₹9 Cr
EBITDA₹-32 Cr₹2 Cr₹5 Cr₹2 Cr₹10 Cr₹-1 Cr₹-1 Cr₹0 Cr
Net Profit₹-54 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹-3 Cr₹0 Cr₹0 Cr
EPS————0.05———
Balance Sheet
MetricMar 2025
Total Assets₹1,720 Cr
Total Liabilities₹1,676 Cr
Equity₹44 Cr
Total Debt—
Cash Flow
MetricMar 2025
Operating₹-1,135 Cr
Investing₹0 Cr
Financing₹1,136 Cr
Free Cash Flow₹-1,135 Cr
Shareholding
Promoter 1.13% Institutions 1.7% Public 97.17%
Efficiency & Working Capital
ROCE0%
Interest Coverage1.6
Dividend Payout—
Debtor Days695 d
Inventory Days243 d
Payable Days451 d
Cash Conversion Cycle486 d
Working Capital Days938 d
Shareholding Details

As of 2025-12-31

Promoter1.1%
FII1.7%
DII0%
Institutions1.7%
Public97.2%
Promoter Pledge0%
No. of Shareholders1,11,269
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJul 2023Sept 2023Dec 2023Mar 2024Jun 2024Jul 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025
Promoters1.1%1.1%1.1%1.1%1.1%1.1%1.1%1.1%1.1%1.1%1.1%1.1%
FIIs0%0.1%0%0%0%0%0%0%0%0%0%1.7%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public98.8%98.8%98.8%98.8%98.9%98.9%98.9%98.9%98.9%98.9%98.9%97.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,0653,9883,85915,58726,46441,56567,40473,6371,10,4221,13,5431,14,1191,11,269
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Uppinangady Sudhindra NayakPublic Shareholding3.2%2.82 Cr
Manju DeviPublic Shareholding2.5%2.17 Cr
L7 Hitech Private LimitedPublic Shareholding2.3%2.07 Cr
Kamal AsnaniPublic Shareholding2.2%1.93 Cr
Zeta Global Funds (oeic) Pcc Limited-zeta Series B Fund PcPublic Shareholding1.7%1.50 Cr
Comfort Capital Private LimitedPublic Shareholding1.7%1.46 Cr
Randeep SinghPublic Shareholding1.2%1.08 Cr
Siddharth Chimanlal ShahShareholding of Promoter and Promoter Group1.1%99,45,600
Krishna Kumar GoyalPublic Shareholding1.1%94,86,069
Vignesh Prabhu HejamadiPublic Shareholding1.1%93,65,285
Board of Directors
NameDesignationYear
Adarsh Deepak MunjalWhole-time Director2025
Dipesh VaidyaIndependent Non Exe. Director2025
Shamim Adil MichalIndependent Non Exe. Director2025
Bikram Kumar MundIndependent Non Exe. Director2025
VIJAY PAL SINGH GULYAIndependent Non Exe. Director2025
Kapil GoplaniCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹11104040
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000101
2025000101
2025000101
Company Information
Incorporated1988
AuditorTaori Sandeep & Associates
Investor Email[email protected]; [email protected]
🌐 www.remlife.com ↗

📍 Office No 601 Hyder Park, Saki Vihar Road Andheri East, Mumbai, Maharashtra, 400072

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Agribio Spirits LimitedNarayana HrudayalayaF Mec International Financial Services Ltd.F Mec International Financial Services Ltd.Deep Health AI India LimitedMalt Land Distilleries LimitedShivansh Finserv LimitedMishtann Foods LimitedDelta Industrial Resources Ltd.Ampl Capital LimitedCredent Global Finance LimitedKotia Enterprises LimitedAll “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App